Resources

Development of a method for the detection of doping with all forms of recombinant Erythropoitins in human blood

Development Beta2 adrenoreceptor agonist and elite athletes pharmacokinetics, physiological and pharmacogenetic

Improving the traceability of steroid abuse by introduction of 2H/1H-analysis of urinary steroids

Heparin: (more than) a masking agent in Epo-doping control

Storage contamination as a potential diagnostic test for autologous blood transfusion

The impact of gender, race and hydration status on the ergogenic and pharmacokinetic impact of short acting β2-Agonists